Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other ...
INDEPENDENCE — A Jesup man will spend up to half a century behind bars for repeatedly shaking and striking his infant son last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results